Skip to main content

Urology

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bright Uro
Bright UroCA - Irvine
1 program
Glean Urodynamics SystemN/A1 trial
Active Trials
NCT07425015Recruiting101Est. Jun 2027
Laborie
LaborieNH - Portsmouth
1 program
Peritron+N/A1 trial
Active Trials
NCT02746406Completed5

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Bright UroGlean Urodynamics System
LaboriePeritron+

Clinical Trials (2)

Total enrollment: 106 patients across 2 trials

NCT07425015Bright UroGlean Urodynamics System

Ambulatory Long Length URodynamics Evaluation

Start: Feb 2026Est. completion: Jun 2027101 patients
N/ARecruiting

A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use

Start: Feb 20165 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 106 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.